Dimer

Dimer

Fibrinolytic enzyme dissolves cross-linked fibrin clots in the blood, and one of the specific degradation products is D-dimer. The increase of D-dimer level indicates the existence of hypercoagulability and secondary hyperfibrinolysis in vivo.

Therefore, we use D-dimer detection reagent in the clinical diagnosis of diffuse intravascular coagulation (DIC), deep vein thrombosis (DVT), pulmonary embolism, myocardial infarction, cerebral infarction, etc. We can use the D-dimer level for diagnosing thrombotic diseases and for the dosage monitoring and therapeutic effect observation of thrombolytic medicines.

SEKBIO is now offering Mouse anti-human D-Dimer mAb and Humanized anti-human D-Dimer mAb for D-Dimer detection usage.

D-Dimer

Fibrinolytic enzymes break down cross-linked fibrin clots in the blood, and one of the specific degradation products is D-Dimer. An increase in D-Dimer levels indicates the presence of hypercoagulability and secondary hyperfibrinolysis in the body.

Indicator of Coagulation Disorders: Elevated D-Dimer levels are commonly seen in conditions involving abnormal blood clotting, such as deep vein thrombosis (DVT), pulmonary embolism (PE), myocardial infarction (MI), and cerebral infarction.

Diagnostic Tool for Thrombotic Diseases: D-Dimer testing is used clinically to help diagnose conditions like diffuse intravascular coagulation (DIC) and monitor thrombolytic therapy effectiveness.

Clinical Applications:

• Disease Diagnosis: D-Dimer levels are used to diagnose thrombotic diseases and to assess the presence of excessive clotting or fibrinolysis.
• Therapeutic Monitoring: D-Dimer testing is also used to monitor the dosage and therapeutic effects of thrombolytic medications.

Sekbio Offerings:

• Mouse anti-human D-Dimer mAb
• Humanized anti-human D-Dimer mAb